Development of siRNA Delivery Strategy by Active Control of Tumor Microenvironment

  • Ishida Tatsuhiro
    Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima
  • Kiwada Hiroshi
    Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima

Bibliographic Information

Other Title
  • 腫瘍内微小環境の能動的制御に基づくsiRNAデリバリー技術の開発とがん治療への展開
  • シュヨウ ナイ ビショウ カンキョウ ノ ノウドウテキ セイギョ ニ モトズク siRNA デリバリー ギジュツ ノ カイハツ ト ガン チリョウ エ ノ テンカイ

Search this article

Description

  Efficient systemic siRNA delivery to cells in the target tissue is a current critical challenge in the drug delivery field. Several studies have demonstrated that nanoparticles such as polyethylene glycol (PEG)-coated siRNA-lipoplexes may enhance the systemic delivery of siRNA to tumor. However, the disordered tumor microenvironment still poses a potential impediment with respect to the efficient delivery of PEG-coated siRNA-lipoplexes. We recently showed that metronomic S-1 dosing (daily oral administration) enhanced the accumulation of PEG-coated liposome containing anticancer drug in solid tumor tissue and thereby increased therapeutic efficacy in tumor-bearing mouse model. To extend this work, we tried to investigate the effect of metronomic S-1 dosing on the intratumoral accumulation of PEG-coated siRNA-lipoplex and, thereby, their therapeutic efficacy in solid tumor-bearing mouse model. Results showed that metronomic S-1 dosing improved systemic delivery of intravenously injected PEG-coated siRNA-lipoplexes into solid tumor tissue. In addition, the combined therapy of S-1 and PEG-coated siRNA-lipoplexes showed potent tumor growth suppressive effect. Our proposed strategy may pose a promising therapeutic one to conquer cancer progression with siRNA.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 133 (3), 379-386, 2013-03-01

    The Pharmaceutical Society of Japan

References(30)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top